SNB
Security National Bank Portfolio holdings
AUM
$578M
This Quarter Return
+10.83%
1 Year Return
+17.2%
3 Year Return
+111.76%
5 Year Return
+213.62%
10 Year Return
–
AUM
$443M
AUM Growth
+$443M
(+24%)
Cap. Flow
+$56.2M
Cap. Flow
% of AUM
12.7%
Top 10 Holdings %
Top 10 Hldgs %
41.92%
Holding
315
New
213
Increased
39
Reduced
33
Closed
2
Top Buys
| 1 |
Berkshire Hathaway Class A
BRK.A
|
$21.7M |
| 2 |
Meritage Homes
MTH
|
$9.84M |
| 3 |
Construction Partners
ROAD
|
$9.73M |
| 4 |
Diamondback Energy
FANG
|
$5.03M |
| 5 |
Southern Copper
SCCO
|
$1.94M |
Top Sells
Sector Composition
| 1 | Technology | 27.87% |
| 2 | Financials | 19.53% |
| 3 | Consumer Discretionary | 13.12% |
| 4 | Industrials | 10.45% |
| 5 | Healthcare | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Vontier
VNT
$6.18B
| $3.77K | ﹤0.01% |
+109
| New | +$3.77K |
|
277
VF Corp
VFC
$5.84B
| $3.76K | ﹤0.01% |
+200
| New | +$3.76K |
|
278
Enbridge
ENB
$105B
| $3.75K | ﹤0.01% |
+104
| New | +$3.75K |
|
279
Southwest Airlines
LUV
$17.1B
| $3.49K | ﹤0.01% |
+121
| New | +$3.49K |
|
280
Weyerhaeuser
WY
$18.1B
| $3.48K | ﹤0.01% |
+100
| New | +$3.48K |
|
281
Amplify Junior Silver Miners ETF
SILJ
$2.03B
| $3.42K | ﹤0.01% |
+342
| New | +$3.42K |
|
282
DXC Technology
DXC
$2.56B
| $3.07K | ﹤0.01% |
+134
| New | +$3.07K |
|
|
BPMC
283
DELISTED
Blueprint Medicines
BPMC
| $2.86K | ﹤0.01% |
+31
| New | +$2.86K |
|
284
MetLife
MET
$53.5B
| $2.78K | ﹤0.01% |
+42
| New | +$2.78K |
|
285
Lattice Semiconductor
LSCC
$8.9B
| $2.62K | ﹤0.01% |
+38
| New | +$2.62K |
|
|
KNDI
286
Kandi Technologies Group
KNDI
$120M
| $2.26K | ﹤0.01% |
+806
| New | +$2.26K |
|
|
CRON
287
Cronos Group
CRON
$965M
| $1.69K | ﹤0.01% |
+808
| New | +$1.69K |
|
288
NorthWestern Energy
NWE
$3.53B
| $1.63K | ﹤0.01% |
+32
| New | +$1.63K |
|
289
Piedmont Lithium
PLL
$159M
| $1.5K | ﹤0.01% |
+53
| New | +$1.5K |
|
290
Zymeworks
ZYME
$1.11B
| $1.4K | ﹤0.01% |
+135
| New | +$1.4K |
|
291
Sibanye-Stillwater
SBSW
$5.82B
| $1.39K | ﹤0.01% |
+255
| New | +$1.39K |
|
|
OGI
292
Organigram Holdings
OGI
$224M
| $1.38K | ﹤0.01% |
+1,050
| New | +$1.38K |
|
293
Standard BioTools
LAB
$477M
| $1.25K | ﹤0.01% |
+565
| New | +$1.25K |
|
294
Charles Schwab
SCHW
$174B
| $1.03K | ﹤0.01% |
+15
| New | +$1.03K |
|
295
iRhythm Technologies
IRTC
$5.51B
| $963 | ﹤0.01% |
+9
| New | +$963 |
|
296
Sundial Growers
SNDL
$643M
| $943 | ﹤0.01% |
+575
| New | +$943 |
|
297
Tandem Diabetes Care
TNDM
$870M
| $769 | ﹤0.01% |
+26
| New | +$769 |
|
298
Vanda Pharmaceuticals
VNDA
$285M
| $625 | ﹤0.01% |
+148
| New | +$625 |
|
299
Pacific Biosciences
PACB
$381M
| $589 | ﹤0.01% |
+60
| New | +$589 |
|
300
AXT Inc
AXTI
$146M
| $576 | ﹤0.01% |
+240
| New | +$576 |
|